Israel is set to begin distributing Regeneron to high-risk patients who become infected with COVID. The idea is to prevent hospitalizations for those who have heart or lung problems, as well as those who are unvaccinated. Regenron is an FDA-approved drug that has been proven to lower the number of hospitalizations. It is a mix of two monoclonal antibodies designed to prevent at-risk COVID-19 patients in mild condition from developing severe illness. It could even prevent hospitalization or death altogether. The treatment would be done at home under the supervision of the patient’s doctor. Please pray that more viable treatments such as this will become more available in Israel. Please also pray for full healing for all who are infected with the virus. Lastly, please pray that Israel will soon emerge from the current wave of infection without more deaths.